20 July 2018
PCM Scientific recently ran a successful, well-attended Journal Club – the NOAC Education platform’s sixth. Professor John Camm returned to host and introduced Dr Stuart Connolly to the attendees of the live webinar.
Dr Connolly, a lead ANNEXA-4 investigator, presented the latest interim analysis of the ongoing ANNEXA-4 study: Andexanet Alfa in Factor Xa Inhibitor-Associated Acute Major Bleeding, which was first presented at ACC.18 in Orlando, Florida.
The RCP-accredited webinar on this FDA-approved (pending in the EU) NOAC reversal agent will shortly be available on the website to anyone who missed out on the night.